Sydney, Australia, 16 July 2018: In a time of rising myopia prevalence, soon to affect half the world’s population, Brien Holden Vision Institute has announced a shift in focus to address future needs both for the ophthalmic industry and the public health sector. The shift will see a redoubling of efforts to strengthen core business – delivering optical inventions and public health solutions to the world.
Professor Kovin Naidoo has resigned as CEO of the both Institute and the Brien Holden Vision Institute Foundation. This allows an opportunity to create a new structure for the businesses. The Board of the Institute announced a two-pronged approach to the development of the group’s new focus.
Ms Yvette Waddell, as new CEO of the Institute, will focus on a translational research response. The role of CEO of the Foundation has traditionally been held by the CEO of the Brien Holden Vision Institute. In a new role, Ms Amanda Davis will take on a dedicated position of Interim CEO to drive the public health response. Click here to read more.